跳至主要内容
临床试验/NCT00914134
NCT00914134已完成4 期

Effect of Duodenal Levodopa Infusion on Quality of Life and Autonomic Dysfunction in Patients With Parkinson's Disease

University of Helsinki1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2009年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
12
试验地点
1
主要终点
Orthostatic blood pressure change

研究概览

简要总结

The aim of the study is to assess the effect of continuous levodopa infusion on autonomic nervous system in patients with Parkinson's Disease (PD), blood pressure regulation and sweating. The investigators' hypothesis is that levodopa infusion may alleviate hyperhidrosis and orthostatic hypotension.

详细描述

Parkinson's disease (PD) is one of the most common neurodegenerative disorders with increasing prevalence because of aging population. The main symptoms include rigidity, hypokinesia, tremor and impaired balance, but the disease also causes autonomic dysfunction. Motor fluctuations are common treatment related problems in PD, around 50-70% of patients treated with levodopa finally develop motor fluctuations. Continuous duodenal levodopa infusion has been effective in the treatment of motor dysfunction in advanced PD. However, little is known of its effects on autonomic nervous system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of idiopathic Parkinson's disease: diagnosis made at least five years earlier
  • Positive response to levodopa
  • Motor fluctuations that cannot be adequately controlled with oral medication
  • No signs or symptoms of cerebellar dysfunction or vascular parkinsonism

排除标准

  • Severe cognitive symptoms
  • Severe arrythmias
  • Severe asthma or COPD
  • Heart, liver or kidney failure
  • No significant vascular lesions in brain MRI imaging.

研究组 & 干预措施

Levodopa Infusion

Experimental

Patients with advanced Parkinson's disease and motor fluctuations that cannot be adequately controlled with oral medication.

干预措施: Levodopa infusion (Drug)

结局指标

主要结局

Orthostatic blood pressure change

时间窗: Before levodopa infusion, after 3-5 days of levodopa infusion and 2 months after levodopa infusion was started

次要结局

  • Sweating measured by evaporimeter(Before levodopa infusion, after 3-5 days of levodopa infusion, 2 months after levodopa infusion was started)
  • Autonomic nervous system symptoms questionnaire (NMSS)(Before levodopa infusion and 2 months after levodopa infusion was started)
  • Quality of life questionnaire (PDQ-39)(Before levodopa infusion and 2 months after levodopa infusion was started)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验